# Semnur Pharmaceuticals, Inc.: Form 8-K, filed Aug 22, 2025

- Company: [Semnur Pharmaceuticals, Inc.](/companies/smnr.md) (CIK 1913577)
- Form: 8-K
- Filed: 2025-08-22
- Accepted by EDGAR: Aug 21, 2025, 20:27 ET
- Period: 2025-08-20
- Accession: 0001213900-25-079504
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1913577/000121390025079504/ea0254236-8k425_denali.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1913577/000121390025079504/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1913577/000121390025079504/ea0254236-8k425_denali.htm

Filed Aug 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-079504. Last ingested by Listed: Nov 4, 2026, 17:17 ET. No prices; not investment advice.